AMICUS THERAPEUTICS, INC. — Director's Dealing 2021

Apr 19, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AMICUS THERAPEUTICS, INC. (FOLD)
CIK: 0001178879
Period of Report: 2021-04-15

Reporting Person: Prout Samantha (Principal Accounting Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-04-15	Common Stock	A	24201	—	Acquired	88875	Direct
2021-04-15	Common Stock	F	660	$10.33	Disposed	88215	Direct

Footnotes

F1: Granted in the form of Restricted Stock Units. Each Restricted Stock Unit represents a contingent right to receive one share of Amicus common stock.

F2: The Restricted Stock Units will vest over a three year period, with 50% of the grant vesting on the second anniversary of the grant date and the remaining 50% vesting on the third anniversary of the grant date.